MedTrace Logo

Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion

NCT02485444 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2023-02-28

No results posted yet for this study

Summary

This study compares oxytocin infusion to spontaneous follow-up for third-stage of labor at induced mid-trimester abortions. Patients will be randomized to oxytocin infusion or observation with no pharmacologic intervention. Primary outcome of the study is complete abortion rate within two hours of fetal delivery.

Conditions

  • Abortion, Induced
  • Labor Stage, Third/Drug Effects
  • Pregnancy Trimester, Second
  • Oxytocin/Administration & Dosage

Interventions

DRUG

Oxytocin

20 IU oxytocin in 500 ml normal saline will be infused 100 ml/h i.v. after fetus is delivered

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Principal Investigators

  • Omer E Yapca, MD · Ataturk University

  • Ragıp A AL, MD · Ataturk University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-08
Primary Completion
2016-05-31
Completion
2016-06-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02485444 on ClinicalTrials.gov